Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations
AI Ritchie, JA Wedzicha - Clinics in chest medicine, 2020 - chestmed.theclinics.com
Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are episodes of
symptom worsening 1 that have significant adverse consequences for patients. 2 The …
symptom worsening 1 that have significant adverse consequences for patients. 2 The …
Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
COPD guidelines: a review of the 2018 GOLD report
S Mirza, RD Clay, MA Koslow, PD Scanlon - Mayo Clinic Proceedings, 2018 - Elsevier
Abstract Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018 is a
consensus report published periodically since 2001 by an international panel of health …
consensus report published periodically since 2001 by an international panel of health …
[HTML][HTML] Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD
JA Wedzicha, D Banerji, KR Chapman… - … England Journal of …, 2016 - Mass Medical Soc
Background Most guidelines recommend either a long-acting beta-agonist (LABA) plus an
inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice …
inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice …
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel …
J Vestbo, A Papi, M Corradi, V Blazhko, I Montagna… - The Lancet, 2017 - thelancet.com
Background Limited data are available for the efficacy of triple therapy with two long-acting
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease
W Liang, Y Yang, S Gong, M Wei, Y Ma, R Feng… - Cell host & …, 2023 - cell.com
Progressive lung function decline is a hallmark of chronic obstructive pulmonary disease
(COPD). Airway dysbiosis occurs in COPD, but whether it contributes to disease progression …
(COPD). Airway dysbiosis occurs in COPD, but whether it contributes to disease progression …
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind …
D Singh, A Papi, M Corradi, I Pavlišová, I Montagna… - The Lancet, 2016 - thelancet.com
Background Few data are available for the efficacy of" triple therapy" with two long-acting
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …
Airway mucin concentration as a marker of chronic bronchitis
M Kesimer, AA Ford, A Ceppe… - … England Journal of …, 2017 - Mass Medical Soc
Background Chronic obstructive pulmonary disease (COPD) is characterized by chronic
bronchitic and emphysematous components. In one biophysical model, the concentration of …
bronchitic and emphysematous components. In one biophysical model, the concentration of …
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …
Long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice …
M Macrea, S Oczkowski, B Rochwerg… - American journal of …, 2020 - atsjournals.org
Background: Noninvasive ventilation (NIV) is used for patients with chronic obstructive
pulmonary disease (COPD) and chronic hypercapnia. However, evidence for clinical …
pulmonary disease (COPD) and chronic hypercapnia. However, evidence for clinical …